1. A replication system comprising:
a copy source storage system configured to store a copy source file system that includes storage data and key data referring to the storage data and being unique depending on the data referred to thereby; and
a copy destination storage system configured to become a copy destination of the copy source file system stored in the copy source storage system,
the replication system also comprising:
a copy processing unit configured to copy the copy source file system stored in the copy source storage system into the copy destination storage system, and form a copy destination file system in the copy destination storage system; and
an update data specifying unit configured to compare the key data within the copy source file system with the key data within the copy destination file system and specify, as update data, the storage data within the copy source file system referred to by the key data within the copy source file system, the storage data not existing in the copy destination file system,
wherein the copy processing unit is configured to copy the update data stored within the copy source file system into the copy destination file system.
2. The replication system according to claim 1, wherein:
as the key data, there are data referring to the storage data and data referring to metadata including one or plural other key data, and the key data form a hierarchical structure; and
the update data specifying unit is configured to, in a case that the key data within the copy source file system that does not exist in the copy destination file system refers to the metadata as a result of comparison of the key data, compare the key data included in the metadata as a comparison target with the key data within the copy destination file system.
3. The replication system according to claim 2, wherein the update data specifying unit is configured to compare the key data and follow a reference destination of the key data within the copy source file system that does not exist in the copy destination file system, thereby specifying the update data.
4. The replication system according to claim 3, wherein the update data specifying unit is configured to compare the key data in order of location from a higher hierarchy to a lower hierarchy and follow a reference destination of the key data.
5. The replication system according to claim 1, wherein the copy processing unit is configured to copy update data stored in the copy source file system and specified by the update data specifying unit, and the key data considered by the update data specifying unit not to exist within the copy destination file system, into the copy destination file system.
6. The replication system according to claim 2, wherein the copy processing unit is configured to copy update data stored in the copy source file system and specified by the update data specifying unit, the key data considered by the update data specifying unit not to exist within the copy destination file system, and the metadata including the key data, into the copy destination file system.
7. The replication system according to claim 1, comprising a unique information generating unit configured to generate unique information depending on data referred to by the key data and to include the information into the key data.
8. The replication system according to claim 7, wherein the unique information generating unit is configured to, when the data referred to by the key data changes by storage of the update data into the copy source file system, generate unique information depending on the data and include the information into the key data referring to the data.
9. A replication device comprising:
a copy processing unit configured to copy a copy source file system stored in a copy source storage system storing the copy source file system that includes storage data and key data referring to the storage data and being unique depending on the data referred to thereby, into a copy destination storage system, and form a copy destination file system in the copy destination storage system; and
an update data specifying unit configured to compare the key data within the copy source file system with the key data within the copy destination file system and specify, as update data, the storage data within the copy source file system referred to by the key data within the copy source file system, the storage data not existing in the copy destination file system,
wherein the copy processing unit is configured to copy the update data stored within the copy source file system into the copy destination file system.
10. The replication device according to claim 9
as the key data, there are data referring to the storage data and data referring to metadata including one or plural other key data, and the key data form a hierarchical structure; and
the update data specifying unit is configured to, in a case that the key data within the copy source file system that does not exist in the copy destination file system refers to the metadata as a result of comparison of the key data, compare the key data included in the metadata as a comparison target with the key data within the copy destination file system.
11. (canceled)
12. (canceled)
13. A replication method comprising:
copying a copy source file system stored in a copy source storage system storing the copy source file system that includes storage data and key data referring to the storage data and being unique depending on the data referred to thereby, into a copy destination storage system, and forming a copy destination file system in the copy destination storage system;
comparing the key data within the copy source file system with the key data within the copy destination file system, and specifying, as update data, the storage data within the copy source file system referred to by the key data within the copy source file system, the storage data not existing in the copy destination file system; and
copying the update data stored within the copy source file system into the copy destination file system.
14. The replication method according to claim 13, wherein:
in a case that, as the key data, there are data referring to the storage data and data referring to metadata including one or plural other key data, and the key data form a hierarchical structure,
when the key data within the copy source file system that does not exist in the copy destination file system refers to the metadata as a result of comparison of the key data at the time of specification of the update data, comparing the key data included in the metadata as a comparison target with the key data within the copy destination file system.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An optically isotropic liquid crystal composition having a liquid crystal component comprising a liquid crystal component A consisting of one or more compounds represented by general formula (1-1) or (1-2) and chiral dopants, wherein in the liquid crystal component, the content of compounds having 3 to 5 ring structures is approximately 15 wt % or more,
and wherein in formulae (1-1) and (1-2):
R1 is alkenyl having 2 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkenyl can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CH\u2550CH\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkenyl can be replaced by halogen;
Ring A1, Ring A2, Ring A3 and Ring A4 are each independently a benzene ring, a naphthalene ring, a cyclohexene ring, a bicyclooctane ring or a cyclohexane ring, wherein any hydrogen in these rings can be replaced by halogen; any \u2014CH2\u2014 in the rings can be replaced by \u2014O\u2014 or \u2014S\u2014; and any \u2014CH\u2550 in the rings can be replaced by \u2014N\u2550;
Z0 is a single bond or alkylene having 1 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
Z1, Z2, Z3 and Z4 are each independently a single bond or alkylene having 1 to 4 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
L1 and L2 are each independently hydrogen or halogen;
X1 is halogen, \u2014C\u2261N, \u2014N\u2550C\u2550S, \u2014C\u2261C\u2014C\u2261N, \u2014SF5, \u2014CHF2, \u2014CF3, \u2014CF2CH2F, \u2014CF2CHF2, \u2014CF2CF3, \u2014(CF2)3\u2014F, \u2014CF2CHFCF3, \u2014CHFCF2CF3, \u2014(CF2)4\u2014F, \u2014(CF2)5\u2014F, \u2014OCHF2, \u2014OCF3, \u2014OCF2CH2F, \u2014OCF2CHF2, \u2014OCH2CF3, \u2014OCF2CF3, \u2014O\u2014(CF2)3\u2014F, \u2014OCF2CHFCF3, \u2014OCHFCF2CF3, \u2014O\u2014(CF2)4\u2014F, \u2014O\u2014(CF2)5\u2014F, \u2014CH\u2550CF2, \u2014CH\u2550CHCF3 or \u2014CH\u2550CHCF2CF3; and
l, m, n and o are each independently 0 or 1; and
l+m+n+o\u22671;
wherein the liquid crystal component does not contain a liquid crystal component D consisting of at least one compound selected from the group consisting of compounds represented by general formulae (7) to (9),
and wherein in the formulae:
R4 and R5 are each independently alkyl having 1 to 10 carbon atoms or alkenyl having 2 to 10 carbon atoms, wherein any \u2014CH2\u2014 in the alkyl and the alkenyl can be replaced by \u2014O\u2014;
Ring D1, Ring D2 and Ring D3 are each independently 1,4-cyclohexylene, pyrimidine-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 3-fluoro-1,4-phenylene or 2,5-difluoro-1,4-phenylene;
Z9 and Z10 are each independently \u2014C\u2261C\u2014, \u2014COO\u2014, \u2014(CH2)2\u2014, \u2014CH\u2550CH\u2014 or a single bond; and
wherein the liquid crystal component has a value of \u0394n\xd7\u0394\u03b5\u22673.39, when there is no chiral dopant.
2. An optically isotropic liquid crystal composition having a liquid crystal component comprising a liquid crystal component A consisting of one or more compounds represented by general formula (1-1) or (1-2) and chiral dopants, wherein in the liquid crystal component, the content of the liquid crystal component A is approximately 15 wt % or more in the liquid crystal component,
and wherein in formulae (1-1) and (1-2):
R1 is alkenyl having 2 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkenyl can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CH\u2550CH\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkenyl can be replaced by halogen;
Ring A1, Ring A2, Ring A3 and Ring A4 are each independently a benzene ring, a naphthalene ring, a cyclohexene ring, a bicyclooctane ring or a cyclohexane ring, wherein any hydrogen in these rings can be replaced by halogen; any \u2014CH2\u2014 in the rings can be replaced by \u2014O\u2014 or \u2014S\u2014; and any \u2014CH\u2550 in the rings can be replaced by \u2014N\u2550;
Z0 is a single bond or alkylene having 1 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
Z1, Z2, Z3 and Z4 are each independently a single bond or alkylene having 1 to 4 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
L1 and L2 are each independently hydrogen or halogen;
X1 is halogen, \u2014C\u2261N, \u2014N\u2550C\u2550S, \u2014C\u2261C\u2014C\u2261N, \u2014SF5, \u2014CHF2, \u2014CF3, \u2014CF2CH2F, \u2014CF2CHF2, \u2014CF2CF3, \u2014(CF2)3\u2014F, \u2014CF2CHFCF3, \u2014CHFCF2CF3, \u2014(CF2)4\u2014F, \u2014(CF2)5\u2014F, \u2014OCHF2, \u2014OCF3, \u2014OCF2CH2F, \u2014OCF2CHF2, \u2014OCH2CF3, \u2014OCF2CF3, \u2014O\u2014(CF2)3\u2014F, \u2014OCF2CHFCF3, \u2014OCHFCF2CF3, \u2014O\u2014(CF2)4\u2014F, \u2014O\u2014(CF2)5\u2014F, \u2014CH\u2550CF2, \u2014CH\u2550CHCF3 or \u2014CH\u2550CHCF2CF3;
l, m, n and o are each independently 0 or 1; and
l+m+n+o\u22672,
wherein the liquid crystal component does not contain a liquid crystal component D consisting of at least one compound selected from the group consisting of compounds represented by general formulae (7) to (9),
and wherein in the formulae:
R4 and R5 are each independently alkyl having 1 to 10 carbon atoms or alkenyl having 2 to 10 carbon atoms, wherein any \u2014CH2\u2014 in the alkyl and the alkenyl can be replaced by \u2014O\u2014;
Ring D1, Ring D2 and Ring D3 are each independently 1,4-cyclohexylene, pyrimidine-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 3-fluoro-1,4-phenylene or 2,5-difluoro-1,4-phenylene;
Z9 and Z10 are each independently \u2014C\u2261C\u2014, \u2014COO\u2014, \u2014(CH2)2\u2014, \u2014CH\u2550CH\u2014 or a single bond; and
wherein the liquid crystal component has a value of \u0394n\xd7\u0394\u03b5\u22673.39, when there is no chiral dopant.
3. An optically isotropic liquid crystal composition having a liquid crystal component comprising a liquid crystal component A consisting of one or more compounds represented by general formula (1-1) or (1-2) and chiral dopants, wherein in the liquid crystal component, the content of compounds represented by l+m+n+o\u22672 in formula (1-1) or (1-2) is approximately 15 wt % or more, and the content of compounds represented by l+m+n+o=1 is approximately 0.1 to approximately 85 wt %,
and wherein in formulae (1-1) and (1-2):
R1 is alkenyl having 2 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkenyl can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CH\u2550CH\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkenyl can be replaced by halogen;
Ring A1, Ring A2, Ring A3 and Ring A4 are each independently a benzene ring, a naphthalene ring, a cyclohexene ring, a bicyclooctane ring or a cyclohexane ring, wherein any hydrogen in these rings can be replaced by halogen; any \u2014CH2\u2014 in the rings can be replaced by \u2014O\u2014 or \u2014S\u2014; and any \u2014CH\u2550 in the rings can be replaced by \u2014N\u2550;
Z0 is a single bond or alkylene having 1 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
Z1, Z2, Z3 and Z4 are each independently a single bond or alkylene having 1 to 4 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
L1 and L2 are each independently hydrogen or halogen;
X1 is halogen, \u2014C\u2261N, \u2014N\u2550C\u2550S, \u2014C\u2261C\u2014C\u2261N, \u2014SF5, \u2014CHF2, \u2014CF3, \u2014CF2CH2F, \u2014CF2CHF2, \u2014CF2CF3, \u2014(CF2)3\u2014F, \u2014CF2CHFCF3, \u2014CHFCF2CF3, \u2014(CF2)4\u2014F, \u2014(CF2)5\u2014F, \u2014OCHF2, \u2014OCF3, \u2014OCF2CH2F, \u2014OCF2CHF2, \u2014OCH2CF3, \u2014OCF2CF3, \u2014O\u2014(CF2)3\u2014F, \u2014OCF2CHFCF3, \u2014OCHFCF2CF3, \u2014O\u2014(CF2)4\u2014F, \u2014O\u2014(CF2)5\u2014F, \u2014CH\u2550CF2, \u2014CH\u2550CHCF3 or \u2014CH\u2550CHCF2CF3; and
l, m, n and o are each independently 0 or 1,
wherein the liquid crystal component does not contain a liquid crystal component D consisting of at least one compound selected from the group consisting of compounds represented by general formulae (7) to (9),
and wherein in the formulae:
R4 and R5 are each independently alkyl having 1 to 10 carbon atoms or alkenyl having 2 to 10 carbon atoms, wherein any \u2014CH2\u2014 in the alkyl and the alkenyl can be replaced by \u2014O\u2014;
Ring D1, Ring D2 and Ring D3 are each independently 1,4-cyclohexylene, pyrimidine-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 3-fluoro-1,4-phenylene or 2,5-difluoro-1,4-phenylene;
Z9 and Z10 are each independently \u2014C\u2261C\u2014, \u2014COO\u2014, \u2014(CH2)2\u2014, \u2014CH\u2550CH\u2014 or a single bond; and
wherein the liquid crystal component has a value of \u0394n\xd7\u0394\u03b5\u22673.39, when there is no chiral dopant.
4. An optically isotropic liquid crystal composition having a liquid crystal component comprising a liquid crystal component A consisting of one or more compounds represented by general formula (1-1) or (1-2) and a liquid crystal component B consisting of one or more compounds represented by general formula (1-3) and chiral dopants, wherein in the liquid crystal component, the content of the liquid crystal component B is approximately 15 to approximately 99.5 wt % or more,
and wherein in formulae (1-1) and (1-2):
R1 is alkenyl having 2 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkenyl can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CH\u2550CH\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkenyl can be replaced by halogen;
Ring A1, Ring A2, Ring A3 and Ring A4 are each independently a benzene ring, a naphthalene ring, a cyclohexene ring, a bicyclooctane ring or a cyclohexane ring, wherein any hydrogen in these rings can be replaced by halogen; any \u2014CH2\u2014 in the rings can be replaced by \u2014O\u2014 or \u2014S\u2014; and any \u2014CH\u2550 in the rings can be replaced by \u2014N\u2550;
Z0 is a single bond or alkylene having 1 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
Z1, Z2, Z3 and Z4 are each independently a single bond or alkylene having 1 to 4 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen can be replaced by halogen;
L1 and L2 are each independently hydrogen or halogen;
X1 is halogen, \u2014C\u2261N, \u2014N\u2550C\u2550S, \u2014C\u2261C\u2014C\u2261N, \u2014SF5, \u2014CHF2, \u2014CF3, \u2014CF2CH2F, \u2014CF2CHF2, \u2014CF2CF3, \u2014(CF2)3\u2014F, \u2014CF2CHFCF3, \u2014CHFCF2CF3, \u2014(CF2)4\u2014F, \u2014(CF2)5\u2014F, \u2014OCHF2, \u2014OCF3, \u2014OCF2CH2F, \u2014OCF2CHF2, \u2014OCH2CF3, \u2014OCF2CF3, \u2014O\u2014(CF2)3\u2014F, \u2014OCF2CHFCF3, \u2014OCHFCF2CF3, \u2014O\u2014(CF2)4\u2014F, \u2014O\u2014(CF2)5\u2014F, \u2014CH\u2550CF2, \u2014CH\u2550CHCF3 or \u2014CH\u2550CHCF2CF3; and
l, m, n and o are each independently 0 or 1,
and wherein in general formula (1-3):
R2 is hydrogen or alkyl having 1 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkyl can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkyl can be replaced by halogen;
Ring A1, Ring A2, Ring A3 and Ring A4 are each independently a benzene ring, a naphthalene ring, a cyclohexene ring, a bicyclooctane ring or a cyclohexane ring, wherein any hydrogen in these rings can be replaced by halogen; any \u2014CH2\u2014 in the rings can be replaced by \u2014O\u2014 or \u2014S\u2014; and any \u2014CH\u2550 in the rings can be replaced by \u2014N\u2550;
Z1, Z2, Z3 and Z4 are each independently a single bond or alkylene having 1 to 4 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkylene can be replaced by halogen;
L1 and L2 are each independently hydrogen or halogen;
X1 is halogen, \u2014C\u2261N, \u2014N\u2550C\u2550S, \u2014C\u2261C\u2014C\u2261N, \u2014SF5, \u2014CHF2, \u2014CF3, \u2014CF2CH2F, \u2014CF2CHF2, \u2014CF2CF3, \u2014(CF2)3\u2014F, \u2014CF2CHFCF3, \u2014CHFCF2CF3, \u2014(CF2)4\u2014F, \u2014(CF2)5\u2014F, \u2014OCHF2, \u2014OCF3, \u2014OCF2CH2F, \u2014OCF2CHF2, \u2014OCH2CF3, \u2014OCF2CF3, \u2014O\u2014(CF2)3\u2014F, \u2014OCF2CHFCF3, \u2014OCHFCF2CF3, \u2014O\u2014(CF2)4\u2014F, \u2014O\u2014(CF2)5\u2014F, \u2014CH\u2550CF2, \u2014CH\u2550CHCF3 or \u2014CH\u2550CHCF2CF3; and
l and m are each independently 0 or 1; and
l+m\u22671;
wherein the liquid crystal component does not contain a liquid crystal component D consisting of at least one compound selected from the group consisting of compounds represented by general formulae (7) to (9),
and wherein in the formulae:
R4 and R5 are each independently alkyl having 1 to 10 carbon atoms or alkenyl having 2 to 10 carbon atoms, wherein any \u2014CH2\u2014 in the alkyl and the alkenyl can be replaced by \u2014O\u2014;
Ring D1, Ring D2 and Ring D3 are each independently 1,4-cyclohexylene, pyrimidine-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 3-fluoro-1,4-phenylene or 2,5-difluoro-1,4-phenylene;
Z9 and Z10 are each independently \u2014C\u2261C\u2014, \u2014COO\u2014, \u2014(CH2)2\u2014, \u2014CH\u2550CH\u2014 or a single bond; and
wherein the liquid crystal component has a value of \u0394n\xd7\u0394\u03b5\u22673.39, when there is no chiral dopant.
5. The optically isotropic liquid crystal composition according to claim 1, wherein in the liquid crystal component A, the content of the compounds represented by general formula (1-1) is approximately 5 to approximately 85 wt %.
6. The optically isotropic liquid crystal composition according to claim 1, wherein in the liquid crystal component, the content of the liquid crystal component A is approximately 40 to approximately 85 wt %.
7. The optically isotropic liquid crystal composition according to claim 1, wherein in the liquid crystal component, the content of the liquid crystal component A is approximately 70 to approximately 85 wt %.
8. The optically isotropic liquid crystal composition according to claim 1, wherein in the optically isotropic liquid crystal composition, the content of the liquid crystal component A is approximately 70 to approximately 84 wt %.
9. The optically isotropic liquid crystal composition according to claim 1, wherein R1 in general formula (1-2) is represented by any one of the formulae selected from the group consisting of the following formulae (CHN-1) to (CHN-12),
and wherein in formulae (CHN-1) to (CHN-12), each R1a is independently hydrogen or alkyl having 1 to 10 carbon atoms.
10. The optically isotropic liquid crystal composition according to claim 1, wherein in the liquid crystal component, the difference between the upper limit and the lower limit of a temperature allowing coexistence of a nematic phase and a non-liquid crystalline isotropic phase is approximately 3\xb0 C. to approximately 150\xb0 C.
11. The optically isotropic liquid crystal composition according to claim 1, comprising the chiral dopants in an amount of 1 to approximately 40 wt % of the total weight of the liquid crystal composition.
12. The optically isotropic liquid crystal composition according to claim 1, comprising the chiral dopants in an amount of approximately 5 to approximately 15 wt % of the total weight of the liquid crystal composition.
13. The optically isotropic liquid crystal composition according to claim 1, wherein the chiral dopants comprise one or more compounds represented by any one of the following formulae (K1) to (K5),
and wherein in formulae (K1) to (K5):
each RK is independently hydrogen, halogen, \u2014C\u2261N, \u2014N\u2550C\u2550O, \u2014N\u2550C\u2550S or alkyl having 1 to 20 carbon atoms, wherein any \u2014CH2\u2014 in the alkyl can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkyl can be replaced by halogen;
each A is independently an aromatic or nonaromatic 3- to 8-membered ring or a condensed ring having 9 or more carbon atoms, wherein any hydrogen in these rings can be replaced by halogen, alkyl having 1 to 3 carbon atoms or haloalkyl; \u2014CH2\u2014 in the rings can be replaced by \u2014O\u2014, \u2014S\u2014 or \u2014NH\u2014; and CH\u2550 in the rings can be replaced by \u2014N\u2550;
each Z is independently a single bond or alkylene having 1 to 8 carbon atoms, wherein any \u2014CH2\u2014 in the alkylene can be replaced by \u2014O\u2014, \u2014S\u2014, \u2014COO\u2014, \u2014OCO\u2014, \u2014CSO\u2014, \u2014OCS\u2014, \u2014N\u2550N\u2014, \u2014CH\u2550N\u2014, \u2014N\u2550CH\u2014, \u2014N(O)\u2550N\u2014, \u2014N\u2550N(O)\u2014, \u2014CH\u2550CH\u2014, \u2014CF\u2550CF\u2014 or \u2014C\u2261C\u2014; and any hydrogen in the alkylene can be replaced by halogen;
each X is independently a single bond, \u2014COO\u2014, \u2014CH2O\u2014, \u2014CF2O\u2014, \u2014OCO\u2014, \u2014OCH2\u2014, \u2014OCF2\u2014 or \u2014CH2CH2\u2014; and
each mK is independently an integer from 1 to 4.
14. The optically isotropic liquid crystal composition according to claim 1, wherein the chiral dopants comprise one or more compounds represented by any one of the following formulae (K2-1) to (K2-8) and (K5-1) to (K5-3),
and wherein in formulae (K2-1) to (K2-8) and (K5-1) to (K5-3):
each RK is independently alkyl having 1 to 10 carbon atoms, wherein \u2014CH2\u2014 adjacent to the ring in the alkyl can be replaced by \u2014O\u2014; and any \u2014CH2\u2014 in the alkyl can be replaced by \u2014CH\u2550CH\u2014.
15. The optically isotropic liquid crystal composition according to claim 1, further comprising one or more agents selected from the group consisting of antioxidants and ultraviolet absorbers.
16. The optically isotropic liquid crystal composition according to claim 1, wherein an optically isotropic liquid crystal phase does not show diffracted light with two or more colors.
17. The optically isotropic liquid crystal composition according to claim 1, wherein an optically isotropic liquid crystal phase shows diffracted light with two or more colors.
18. The optically isotropic liquid crystal composition according to claim 1, which exhibits a chiral nematic phase at approximately \u221220\xb0 C. to approximately 70\xb0 C., and wherein in at least a part of the temperature range, the spiral pitch is approximately 700 nm or less.
19. A mixture comprising the optically isotropic liquid crystal composition according to claim 1 and a polymerizable monomer.
20. The mixture according to claim 19, wherein the polymerizable monomer is a photopolymerizable monomer or a thermopolymerizable monomer.
21. A polymerliquid crystal composite for use in an element driven in a state of an optically isotropic liquid crystal phase, which can be obtained by polymerizing the mixture according to claim 19.
22. A polymerliquid crystal composite for use in an element driven in a state of an optically isotropic liquid crystal phase, which can be obtained by polymerizing the mixture according to claim 19 in a state of a non-liquid crystalline isotropic phase or the optically isotropic liquid crystal phase.
23. The polymerliquid crystal composite according to claim 21, wherein a polymer included in the polymerliquid crystal composite has a mesogenic moiety.
24. The polymerliquid crystal composite according to claim 21, wherein the polymer included in the polymerliquid crystal composite has a cross-linked structure.
25. The polymerliquid crystal composite according to claim 21, comprising the liquid crystal composition in an amount of approximately 60 to approximately 99 wt % and the polymer in an amount of 1 to 40 wt %.